UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)  January 13, 2011

 

CANTEL MEDICAL CORP.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-31337

 

22-1760285

(State or other jurisdiction

 

(Commission

 

(IRS Identification

of incorporation)

 

File Number)

 

Number)

 

150 Clove Road, Little Falls, New Jersey

 

07424

Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (973) 890-7220

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07               Submission of Matters to a Vote of Security Holders

 

At the 2010 Annual Meeting of Stockholders of Cantel Medical Corp. (the “Company”) held on January 13, 2011 (the “2010 Annual Meeting”), two proposals were voted on by the Company’s stockholders.  The proposals are described in detail in the Company’s definitive proxy statement filed on November 29, 2010 (the “Proxy Statement”) in connection with the 2010 Annual Meeting.  A brief description of the proposals and the final results of the votes for each matter are as follows:

 

1.               The stockholders elected all ten director nominees to serve as members of the Company’s board of directors until the Company’s 2011 Annual Meeting of Stockholders.

 

Name

 

For

 

Withheld

 

Broker
Non-Votes

 

Robert L. Barbanell

 

13,410,387

 

943,223

 

1,694,463

 

Alan R. Batkin

 

14,166,385

 

187,225

 

1,694,463

 

Joseph M. Cohen

 

13,416,931

 

936,679

 

1,694,463

 

Charles M. Diker

 

13,612,054

 

741,556

 

1,694,463

 

Mark N. Diker

 

13,612,940

 

740,670

 

1,694,463

 

George L. Fotiades

 

14,048,572

 

305,038

 

1,694,463

 

Alan J. Hirschfield

 

13,606,507

 

747,103

 

1,694,463

 

Andrew A. Krakauer

 

13,615,900

 

737,710

 

1,694,463

 

Peter B. Pronovost, M.D.

 

14,080,823

 

272,787

 

1,694,463

 

Bruce Slovin

 

13,606,860

 

746,750

 

1,694,463

 

 

2.               The stockholders ratified the appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending July 31, 2011.

 

For

 

Against

 

Abstain

 

Broker
Non-Votes

15,259,157

 

782,934

 

5,982

 

0

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

CANTEL MEDICAL CORP.

 

 

 

 

 

By:

/s/ Andrew A. Krakauer

 

 

Andrew A. Krakauer

 

 

President and CEO

 

 

Dated: January 18, 2011

 

 

3